Lowe's shares rise following JPMorgan upgrade: 4 big analyst picks By
2024-02-12 21:21:16
more 
1011

— Here is your Pro Recap of the biggest analyst picks you may have missed since today: upgrades at Lowe's, Willis Towers Watson, Teva Pharma, and Urban Outfitters.

InvestingPro users got this news and reacted in real time! Join now and never miss out on another buying opportunity.

Lowe's shares gain on JPMorgan upgrade

Lowe’s Companies (NYSE:) shares rose more than 1% pre-market today after JPMorgan upgraded the company to Overweight from Neutral and raised its price target to $265 from $210, as reported in real-time on InvestingPro.

The bank highlighted several reasons for the upgrade and inclusion on JPM's Analyst Focus List as a Value stock idea:

  1. Moderating headwinds for goods share of wallet, with trends expected to revert towards wage growth.
  2. Specific to the home improvement category, the firm estimates that we are nearing pre-COVID wallet share levels, with DIY (75% of LOW’s mix) experiencing a larger headwind since the start of post-COVID normalization in early 2021.
  3. Market expectations of rate cuts could lower mortgage rates, potentially boosting home sales and, subsequently, home improvement spending.
  4. The potential housing market recovery, despite the locked-in mortgage rate dynamic, could accelerate Lowe's sales beyond conservative consensus expectations.

new year

Willis Towers Watson earns an upgrade at Citi

Citi upgraded Willis Towers Watson (NASDAQ:) to Buy from Neutral, boosting the price target to $315 from $236.

Our 3Q positive catalyst watch was bracketed by our view that one qtr was unlikely to make a trend, but we have since been proven wrong and believe mgmt has honed its guidance craft at an opportune time.

The analysts pointed to the clearer visibility of near-term margin improvements, attributed to cost-saving measures and materially softer H1 comps. The current EPS guidance is viewed as conservative, with margins and buybacks seen as the most likely areas for upside. Overall, Citi believes that a restoration of confidence is underway, which should lead to a sustained improvement in the company's valuation.

Two more upgrades

Piper Sandler upgraded Teva Pharma (NYSE:) to Overweight from Neutra with a price target of $19.00 (from $12.00). As a result, shares gained more than 2% pre-market today.

Urban Outfitters (NASDAQ:) shares rose more than 1% pre-market today after UBS upgraded the company to Neutral from Sell with a price target of $41.00 (from $21.00).

Take your investing game to the next level in 2024 with ProPicks

Institutions and billionaire investors worldwide are already well ahead of the game when it comes to AI-powered investing, extensively using, customizing, and developing it to bulk up their returns and minimize losses.

Now, InvestingPro users can do just the same from the comfort of their own homes with our new flagship AI-powered stock-picking tool: ProPicks.

With our six strategies, including the flagship "Tech Titans", which outperformed the market by a lofty 952% over the last decade, investors have the best selection of stocks in the market at the tip of their fingers every month.

Subscribe here and never miss a bull market again!

new year

Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!

Related News

您正在访问的是FxGecko网站。 FxGecko互联网及其移动端产品是中国香港特别行政区成立的Hitorank Co.,LIMITED旗下运营和管理的一款面向全球发行的企业资讯査询工具。

您的IP为 中国大陆地区,抱歉的通知您,不能为您提供查询服务,还请谅解。请遵守当地地法律。